Date of Annual Meeting: March 11 - 15, 2009 , Miami
Annual Meeting Providers
Content and Speakers
SYMPOSIUM
The Changing Paradigm of Metastatic Colorectal Cancer Moderator: Anton Bilchik, MD
- Management of the “Disappearing” Colorectal Liver
Metastases: Resect or Wait?
Yuman Fong, MD
- Neoadjuvant Therapy and Staged Resections – Do
They Really Work and What is the Downside?
Professor Rene Adam, MD Hospital Paul Brousse, University Paris, France
- Chemotherapy Induced Hepatoxicity: Work-Up and
Therapeutic Strategies
Nick Vauthey, MD, FACS Surgical Oncology, Memorial Sloan-Kettering Cancer Center
New York, NY
- Liver Resection in the Face of Extrahepatic Disease
When is it Indicated?
Mike Choti, , MD, MBA, FACS
Department of Surgery, John Hopkins Medicine, Baltimore, MD
Liver metastases remain the most common site of the spread of colorectal cancer. New therapeutic strategies including improved chemotherapy have enhanced treatment options and challenged traditional management approaches.
Get this session on DVD
AHPBA 2009 DVD 8
Format: live documentary, color
Language: English
Number of discs: 1
Region: PC worldwide, DVD player NTSC
Studio and DVD Release: Medical dTV - 2009
Run Time: 1:22:42
Price: 50.00 USD FREE Standard Shipping Worldwide.
Buy AHPBA 2009 DVD in Collection
AHPBA 2009 DVD 1 - 28 collection View Content List
Language: English
Number of discs: 28
Region: PC worldwide, DVD player NTSC
Studio and DVD Release: Medical dTV - 2009
Run Time: aprox. 32 hours+
Price: 500.00 USD FREE Standard Shipping Worldwide.
Michael A. Choti, MD, MBA,FACS
Department of Surgery, John Hopkins Medicine, Baltimore, MD
Michael A. Choti, M.D. is an Assistant Professor of Surgery and Oncology at the Johns Hopkins University School of Medicine and an Attending Surgeon at the Johns Hopkins Hospital. He is a graduate of the Yale University School of Medicine and received his surgical training at the Hospital of the University of Pennsylvania. After completing his general surgery residency in 1990, Dr. Choti went on for advanced surgical training in surgical oncology at Memorial Sloan-Kettering Cancer Center in New York. In 1992, he joined the full-time faculty at Johns Hopkins University. His major areas of interest are gastrointestinal malignancies including hepatobiliary, pancreatic, and colorectal cancer. His primary research interests include tumor immunology and experimental therapeutics of gastrointestinal malignancies.
